Legislation
Pharma Cheers Health Reform Legislation
After months of increasingly rancorous debate, the House of Representatives finally approved legislation that makes significant changes in the nation’s healthcare system. The Senate is slated to approve the House-passed changes to its original reform bill shortly.
Strategy
GSK and Pfizer to Discount Pneumonia Vaccines for the Poor
Proving that one good turn deserves another, Pfizer and GlaxoSmithKline announced that they would provide millions of doses of pneumonia vaccines to some of the world’s most impoverished countries at massive discounts.
Global
Parallel Importers Framed in Europe
The European debate about combating counterfeit medicines is generating a lot of heat in Brussels.
People
Tauzin’s Farewell to PhRMA
In an emotional farewell address to PhRMA, outgoing President Billy Tauzin recapped his five years at the helm of the organization, and his efforts to “recapture the value of the PhRMA brand” and “re-earn the trust of people who had lost faith in us.”
R&D
A Critical Path to New TB Treatments
FDA Commissioner Margaret Hamburg announced, on Thursday, a new joint initiative between industry, FDA, and nonprofit organizations designed to fast-track modern combination treatments for tuberculosis.
New & Noteworthy
The Race is On
Several leading pharmas may already have a drug for a retrovirus linked to chronic fatigue disease. Has medicine's "problem child" finally earned the industry's respect?
Call for Nominations
Pharmaceutical Executive¹s Emerging Pharma Leadership Award
The pharma industry is facing some tough times‹and the old way of doing things just won¹t work. So just who are the new leaders steering the industry though its most difficult challenges? Which executives are revamping the industry‹through pure innovation‹to remake it for the 21st century?
These emerging leaders are vital to the future of the industry, and you can help ensure that they get the recognition they deserve. Fill out your nomination today! |
|
